Pirarubicin
Top View
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Pirarubicin Reduces USP22 Expression by Inhibiting CREB‑1 Phosphorylation in Hela Cells
- Antineoplastic-Related Cardiovascular Toxicity a Systematic Review And
- United States Patent $835 a 88: As: Inhibitor 1-((R)-3-(4-Amino-3-(4
- Pdf 480.92 K
- Methods for Bladder Cancer Diagnosis – the Role of Autofluorescence And
- Lidocaine Enhances the Effects of Chemotherapeutic Drugs Against
- Biweekly THP-COPBLM (Pirarubicin, Cyclophosphamide, Vincristine
- (12) Patent Application Publication (10) Pub. No.: US 2004/0038904 A1 Ogden (43) Pub
- Effects of Anthracycine Derivatives on Hepatic Neoplastic Nodules of Lewis Lung Carcinoma and Colon Adenocarcinoma 26
- Long‑Term Outcome of 31 Cases of Refractory Acute Promyelocytic
- A Meta-Analysis of Arsenic Trioxide Combined with Transcatheter Arterial Chemoembolization for Treatment of Primary Hepatic Carcinoma
- View a Copy of This Licence, Visit
- Bladder Cancer
- Cytostatics in the Aquatic Environment: Analysis, Occurrence, and Possibilities for Removal
- TOP2A Is Overexpressed and Is a Therapeutic Target for Adrenocortical Carcinoma
- Study Protocol – Version 7 Date:29JUL16 1/144
- Molecular Blueprints for Antitumor Drugs